Release test results
99.722%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 10.08 mg
Related impurities (total)0.278%
Endotoxin<1.0 EU/mg
HPLC retention time4.87 min
MethodHPLC + LC-MS
ResultPass · meets spec
Lot record
CompoundAOD-9604
Presentation10 MG
Lot numberRGX-26-AOD-671
COA numberNS-2026-05134
Test date02 Sep 2026
Release date05 Sep 2026
Independent labNordicstar Labs
StatusSuperseded
AOD-9604 — lot history
| Lot | Presentation | Tested | HPLC purity | Status |
|---|---|---|---|---|
| RGX-26-AOD-1029 | 10 MG | Sep 8, 2026 | 99.624% | Current |
| RGX-26-AOD-771 | 10 MG | Sep 6, 2026 | 99.753% | Superseded |
| RGX-26-AOD-1028 | 5 MG | Sep 4, 2026 | 99.647% | Current |
| RGX-26-AOD-672 | 5 MG | Sep 4, 2026 | 99.715% | Superseded |
| RGX-26-AOD-772 | 5 MG | Sep 3, 2026 | 99.608% | Superseded |
| RGX-26-AOD-671 this lot | 10 MG | Sep 2, 2026 | 99.722% | Superseded |
!
Research use only
This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →